David Weill sold $524K of TransMedics (TMDX)

Executed Mar 4, disclosed Mar 6, 2 days later.

Value, as filed

$524K

3,571 sh × $146.82

Executed

Mar 4

the trade date, as filed

Disclosed

Mar 6

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DW David Weill Director profile →

David Weill (Director) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in TransMedics Group, Inc. (TMDX). The largest single filing was $693K of TMDX (5,000 sh × $138.64, as filed), executed Dec 3 2025. The median gap between execution and disclosure was 3 days.

The name

TMDX TransMedics Group, Inc. TMDX · Healthcare · 21 filings in 24 months ticker →

Healthcare · TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage orga…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David Weill in TMDX

TMDXPURCHASE TransMedics Group, Inc. $109K
1,336 sh × $81.63
Exec Sep 11
Filed Sep 14 · 4:30 PM ET TMDXSALE TransMedics Group, Inc. $693K
5,000 sh × $138.64
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET